Your browser doesn't support javascript.
loading
Reported rates of all-cause serious adverse events following immunization with BNT-162b in 5-17-year-old children in the United States.
Mangat, Halinder S; Rippon, Brady; Reddy, Nikita T; Syed, Akheel A; Maruthanal, Joel M; Luedtke, Susanne; Puthumana, Jyothy J; Srivatsa, Abhinash; Bosman, Arnold; Kostkova, Patty.
Afiliación
  • Mangat HS; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, United States of America.
  • Rippon B; Department of Population Health Sciences, Weill Cornell Medical College, New York, New York, United States of America.
  • Reddy NT; Department of Medical Sciences, Newcastle University, Great Britain, Newcastle upon Tyne, United Kingdom.
  • Syed AA; Faculty of Biology Medicine and Health, The University of Manchester, Manchester, United Kingdom.
  • Maruthanal JM; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, United States of America.
  • Luedtke S; Gesundheitsamt Nuremberg, Nuremberg, Germany.
  • Puthumana JJ; Department of Cardiology, Northwestern Medicine, Chicago, Illinois, United States of America.
  • Srivatsa A; Department of Pediatrics, Boston's Children's Hospital, Boston, Massachusetts, United States of America.
  • Bosman A; Transmissible BV, Public Health Learning Solutions, Utrecht, The Netherlands.
  • Kostkova P; UCL Centre for Public Health in Emergencies (dPHE), University College London, London, United Kingdom.
PLoS One ; 18(2): e0281993, 2023.
Article en En | MEDLINE | ID: mdl-36800368

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos